Related Experiment Video

Updated: Jun 9, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Steroid receptor and microRNA regulation in cancer

Michael A Tessel1, Nancy L Krett, Steven T Rosen

  • 1Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.

Current Opinion in Oncology
|August 27, 2010
PubMed
Abstract

Insights

MicroRNAs (miRNAs) regulate steroid hormone receptors (SHRs) in hormone-responsive cancers. Understanding these interactions offers potential diagnostic biomarkers and therapeutic targets for cancer treatment.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Steroid hormone receptors (SHRs) are key regulators in hormone-dependent cancers.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in cancer pathobiology.
  • The interplay between SHRs and miRNAs in cancer is a critical area of research.

Purpose of the Study:

  • To elucidate the regulatory roles of miRNAs on SHR expression.
  • To investigate the modulation of miRNAs by SHR signaling in cancer.
  • To identify potential diagnostic biomarkers and therapeutic targets based on these interactions.

Main Methods:

  • Review of recent scientific literature on miRNA and SHR interactions in cancer.
  • Analysis of studies detailing miRNA regulation of estrogen receptor, androgen receptor, progesterone receptor, and glucocorticoid receptor.
  • Synthesis of evidence on SHR signaling modulating miRNA expression.

Main Results:

  • Estrogen receptor status is a critical factor in breast cancer prognosis and treatment.
  • Emerging evidence shows miRNAs regulate androgen receptor, progesterone receptor, and glucocorticoid receptor in hormone-responsive cancers.
  • Several miRNAs directly regulate SHR expression, while SHRs also modulate miRNA levels in cancer cells.

Conclusions:

  • Distinct miRNA profiles characterize cancers and influence disease progression.
  • Regulatory interactions between SHRs and miRNAs are implicated in hormone-responsive cancer progression.
  • miRNA-SHR interactions present opportunities for novel prognostic tools and therapeutic strategies in oncology.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...